← Patent Expiry Watch
October 24, 2026 · Patent expires February 17, 2041
GOMEKLI (MIRDAMETINIB): The 2041 Generic Opportunity Window
GOMEKLI (MIRDAMETINIB): The patent core expires on February 17, 2041; ZERO generics currently approved as of October 2026. SCOPE NOTE: Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited (filed 2022-09-28, District Court, D. Delaware)
What we do
We track expirations like this continuously
This is one drug, picked for today's post. A Portfolio Retainer watches an entire portfolio or compound class on an ongoing basis and flags new matching filings as they publish.